The transfection efficacy is shown in Figure S2A. CCK-8 assays showed that MRPL52 overexpression enhanced the viability of BC cells exposed to 20% or 1% O2, whereas knocking down MRPL52 under hypoxia led to decreased numbers of living cells (Figure S2B). Here, MRPL52 is linked to breast cancer.